Dr Seatla’s primary research interests are in the development and implementation of low-cost HIV drug resistance (HIVDR) testing assays and monitoring for HIVDR mutations amongst people living with HIV in low and middle-income countries (LMICs). As a Medical Doctor since 2011, he has been caring for HIV-1 infected individuals in clinics in Botswana, including patients with extensive drug resistance mutations. He has worked on ACTG, IMPAACT and HPTN network trials for over 5 years. Dr Seatla has developed one of the largest sequence datasets of HIV-1 subtype C infected individuals experiencing virological failure whilst on dolutegravir-based treatment. He has also developed a new low cost assay that tests for resistance to dolutegravir at about a quarter of the cost of a commercial/licensed HIVDR assay. Dr Seatla has a PhD in Health Sciences from the University of Botswana where he also serves as Clinical Skills Tutor in the Faculty of Medicine